What is Urology?

Urology: Urinary & Reproductive Disease Diagnosis & Treatment

Urology treats urinary tract diseases in all genders and male reproductive issues, covering the kidneys, bladder, prostate, urethra, from infections to complex cancers.

We're Here to Help.
Get in Touch.

Send us all your questions or requests, and our expert team will assist you.

Doctors

Diagnosis and Tests

Cystoscopy

The diagnostic utility of cystoscopy extends far beyond the simple act of looking inside the bladder. It is a comprehensive diagnostic event that integrates visual data with histological, cytological, and molecular information. In the context of modern urology, the procedure is the central hub of a diagnostic workflow that includes advanced imaging and systemic biomarker analysis. The goal is to achieve a precision diagnosis, one that characterizes the disease not just anatomically but biologically. This level of detail is essential for planning treatments that are minimally invasive and regenerative in nature, preserving the maximum amount of healthy tissue.

During the procedure, the urologist systematically evaluates the urethra, the prostate in men, the bladder neck, the ureteral orifices, and the entire bladder mucosa. This visual inspection is often augmented by enhanced cystoscopic techniques. For instance, the use of contrast agents or retrograde pyelography allows for the evaluation of the upper urinary tract during the same session. Furthermore, the integration of digital health records allows for the real time comparison of current findings with previous exams, creating a longitudinal view of the patient’s urothelial health.

Icon LIV Hospital

Biochemical markers and signaling pathways

  • Urinary NMP22 is a nuclear matrix protein released by apoptotic cells and its elevation in urine can serve as a point of care marker to triage patients for cystoscopy.
  • Cytokeratin fragments such as Cyfra 21 1 are released into the urine by epithelial cell turnover and their quantification aids in the diagnosis of urothelial carcinoma.
  • DNA methylation markers in voided urine can detect epigenetic silencing of tumor suppressor genes providing a highly sensitive tool for detecting recurrence.
  • Survivin is an inhibitor of apoptosis protein expressed in cancer cells and its detection in urine correlates with high grade disease and risk of progression.
  • Hyaluronic acid and hyaluronidase levels in urine can indicate the status of the GAG layer and the turnover of the extracellular matrix in interstitial cystitis.
Icon 1 LIV Hospital

Subspecialties within Urology

Cystoscopy
  • Diagnostic mapping phase involves the systematic inspection of the bladder using landmarks to ensure 100 percent surface area coverage including the difficult to see anterior dome.
  • Provocative testing phase may involve filling the bladder to capacity to reproduce pain symptoms or identify areas of reduced compliance or scarring.
  • Tissue sampling phase utilizes cold cup biopsy forceps to obtain specimens from suspicious areas preserving the architecture for pathological analysis.
  • Upper tract evaluation phase involves the cannulation of the ureteral orifices to inject contrast dye ensuring that hematuria is not originating from the kidneys.
  • Post diagnostic stratification phase involves assigning a clinical stage and grade to any identified pathology guiding the urgency and type of subsequent treatment.

Advanced technological requirements for modern intervention

  • Multiparametric MRI fusion allows for the overlay of cross sectional imaging data onto the live endoscopic view guiding biopsies to areas of suspicion identified on MRI.
  • Confocal laser endomicroscopy utilizes a fiberoptic probe passed through the cystoscope to provide real time microscopic imaging of the cellular structure effectively performing an in vivo biopsy.
  • Optical coherence tomography provides cross sectional images of the bladder wall layers allowing for the assessment of tumor depth and invasion without resection.
  • Digital cytology platforms utilize artificial intelligence to scan urine samples for atypical cells enhancing the sensitivity of standard cytology.
  • Tele urology platforms allow for the remote reviewing of recorded high definition cystoscopy videos by sub specialists facilitating expert second opinions.

Systemic risk factors and metabolic comorbidities

  • Coagulopathy and anticoagulant therapy require careful perioperative management to prevent uncontrolled bleeding from biopsy sites while minimizing thrombotic risk.
  • Immunosuppression increases the risk of post procedural urinary tract infection necessitating extended antibiotic prophylaxis and vigilance.
  • Chronic urinary retention alters the bladder wall architecture making visual interpretation of muscle fibers and diverticula more complex.
  • Pelvic organ prolapse can distort the anatomy of the bladder floor and ureteral orifices requiring advanced maneuvering of the cystoscope to visualize all surfaces.
  • Neurological conditions such as multiple sclerosis can alter bladder sensation and contractility necessitating videourodynamic integration during cystoscopy.

Comparative clinical objectives for regenerative success

Cystoscopy
  • Accurate staging of tumors ensures that patients with muscle invasive disease are triaged to radical therapy while those with superficial disease receive organ sparing regenerative management.
  • Identification of urethral stricture etiology allows for the selection of reconstructive techniques that preserve the urethral blood supply and spongiosum.
  • Verification of ureteral patency is critical for preserving renal function particularly in patients with stones or extrinsic compression.
  • Molecular profiling of biopsy specimens guides the use of targeted systemic therapies and immunotherapies in advanced disease.
  • Minimization of diagnostic invasiveness reduces the risk of iatrogenic injury preserving the structural integrity of the urinary tract for future interventions.

30 Years of
Excellence

Trusted Worldwide

With patients from across the globe, we bring over three decades of medical

Book a Free Certified Online
Doctor Consultation

Clinics/branches

Was this article helpful?

Was this article helpful?

We're Here to Help.
Get in Touch.

Send us all your questions or requests, and our expert team will assist you.

Doctors

FREQUENTLY ASKED QUESTIONS

What is urinary cytology and why is it done with cystoscopy?

Urinary cytology is a laboratory test where a pathologist looks at loose cells shed into the urine under a microscope. It is often performed in conjunction with cystoscopy to detect high grade cancer cells that might be shed from the bladder lining or the upper urinary tract, which might not be visible as a distinct tumor during the cystoscopy. The combination of visual inspection and cytology provides a more comprehensive assessment for malignancy.

A retrograde pyelogram is an imaging test performed during cystoscopy. The doctor inserts a small catheter into the opening of the ureter in the bladder and injects contrast dye upwards towards the kidney. X ray images are then taken to visualize the ureters and kidneys. This is used to diagnose stones, tumors, or blockages in the upper urinary tract that cannot be seen with the cystoscope alone.

Cystoscopy is a valuable part of the workup for urinary incontinence, although it does not diagnose the leakage mechanism itself. It is used to rule out anatomical abnormalities that could be contributing to incontinence, such as a fistula, a diverticulum, bladder stones, or tumors. It also allows the doctor to assess the health of the urethral sphincter and the bladder lining, which helps in planning surgical or regenerative treatments.

If the doctor sees an abnormal area of tissue during the cystoscopy, such as a red patch, a growth, or an ulcer, they will take a small sample called a biopsy. This tissue is sent to a lab for analysis to determine if it is cancer, inflammation, or another condition. Taking a biopsy is a standard diagnostic step and does not necessarily mean that you have cancer, but it provides the definitive information needed to make a diagnosis.

Cystoscopy is the gold standard for detecting bladder cancer and is highly accurate for identifying papillary tumors that grow into the bladder lumen. However, it can sometimes miss flat lesions like carcinoma in situ or small tumors. To improve accuracy, urologists use enhanced techniques like blue light cystoscopy and Narrow Band Imaging, which significantly increase the detection rate of these subtle cancers compared to standard white light cystoscopy.

Spine Hospital of Louisiana

Let's Talk About Your Health

BUT WAIT, THERE'S MORE...

Leave your phone number and our medical team will call you back to discuss your healthcare needs and answer all your questions.

Let's Talk About Your Health

How helpful was it?

helpful
helpful
helpful
Your Comparison List (you must select at least 2 packages)